Obesity is associated with a variety of medical conditions such as type 2 diabetes and cardiovascular diseases and is therefore responsible for high morbidity and mortality rates. Increasing energy expenditure by brown adipose tissue (BAT) is a current novel strategy to reduce the excessive energy stores in obesity. Brown adipocytes burn energy to generate heat and are mainly activated upon cold exposure. As prolonged cold exposure is not a realistic therapy, researchers worldwide are searching for novel ways to activate BAT and/or induce beiging of white adipose tissue. Recently, the contribution of immune cells in the regulation of brown adipocyte activity and beiging of white adipose tissue has gained increased attention, with a prominent role for eosinophils and alternatively activated macrophages. This review discusses the rediscovery of BAT, presents an overview of modes of activation and differentiation of beige and brown adipocytes, and describes the recently discovered immunological pathways that are key in mediating brown/beige adipocyte development and function. Interventions in immunological pathways harbor the potential to provide novel strategies to increase beige and brown adipose tissue activity as a therapeutic target for obesity. (Endocrine Reviews 38: 2017) 
, has nearly doubled since 1980, and at least 2.8 million people die each year as a result of obesity. This number is expected to further increase over the next decade. Obesity leads to adverse effects on blood pressure, plasma lipid levels, and insulin resistance. Health problems related to these adverse effects include coronary artery disease, atherosclerosis, fatty liver disease, type 2 diabetes, cancer, and degenerative diseases (1) . The immune system plays a key role in the pathogenesis of obesity, and extensive research is ongoing to identify critical players involved to find novel therapeutic targets to combat obesity. Currently, adequate treatment options are limited. Interestingly, recent studies show that the activation of beige or brown adipocytes and the subsequent increase in energy expenditure can lower body fat mass and potentially lower adipose tissue inflammation (2) . Moreover, there is increasing evidence that brown and beige adipose tissue function is subject to immune regulation (3-6). Brown and beige adipose tissues are therefore of great interest as a novel therapeutic target for obesity.
II. Brown Adipose Tissue

A. Brown adipose tissue regulates adaptive thermogenesis by mitochondrial uncoupling
Whereas white adipose tissue (WAT) is specialized in the storage of energy, brown adipose tissue (BAT) plays a central role in energy expenditure. Brown adipocytes convert energy from glucose and fatty acids into heat via nonshivering thermogenesis, which contributes to the maintenance of body temperature (7) . The regulation of body temperature is crucial to ensure that cellular functions and physiological processes continue in cold environments (8) . This regulation is particularly important in small organisms with a relatively large surface area. Even newborns of large organisms have distinct depots of BAT that regress with increasing age. BAT in adult humans is most commonly present in the supraclavicular and neck region but also along the vertebrae and aorta and near the kidneys ( Fig. 1) (9) . In rodents, the major BAT depot is found in the interscapular region, whereas smaller depots include axillary BAT, cervical BAT, and perirenal and periaortic BAT ( Fig. 1) (10, 11) .
BAT is highly innervated by the sympathetic nervous system, and a well-structured vascularization enables the supply of oxygen and transport of heat. Brown adipocytes have numerous small lipid droplets for fast energy supply and a large number of mitochondria that can produce heat via mitochondrial uncoupling. The wealth of mitochondria and the extensive vascularization pattern account for their dark color and hence its name: brown adipose tissue.
Cold activates the hypothalamus, which induces sympathetic outflow toward BAT and results in release of noradrenaline by efferent sympathetic nerve endings. Noradrenaline binds to b-adrenergic receptors present on brown but also on white adipocytes (12, 13) . Cold-induced adrenergic-receptor stimulation has both acute and chronic effects on BAT (14) . Acute thermogenesis results in lipolysis, degradation of fatty acids, glucose uptake, and activation of uncoupling protein 1 (UCP1). Chronic activation leads to increased gene transcription of UCP1 and mitochondrial biogenesis (14) . BAT expresses substantial amounts of UCP1, an inner-membrane mitochondrial protein that uncouples oxidative phosphorylation from adenosine triphosphate (ATP) synthesis, resulting in dissipation of energy into heat ( Fig. 2) (15) .
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B. White, beige, and brown adipocytes Currently, 2 distinct types of brown adipocytes, each of a different origin, have been described: the classic brown adipocyte, which is found at distinct anatomical sites in mice, including the interscapular, perirenal, and axillary BAT depots, and the so-called brite or beige adipocytes, which are found within WAT (20) . Inducing these beige adipocytes in WAT is referred to as browning or beiging. Because humans lack a large classic BAT depot, it is attractive to identify approaches to stimulate formation of beige cells within WAT that share functional characteristics with classic brown adipocytes. An important difference between the 2 cell types is that classic brown adipocytes constitutively express UCP1, whereas beige adipocytes only do so upon appropriate stimuli, such as cold and b-adrenergic receptor stimulation (21) (22) (23) . Increased biogenesis of beige adipocytes may contribute to increased energy expenditure, improved metabolic parameters, and improved tolerance to cold.
Microarray analysis as well as in vivo lineage tracing studies showed a common developmental ancestry between the classic brown adipocyte and skeletal muscle cells, in which the common progenitor is myogenic factor 5 (Myf5)-expressing muscle precursor cell (20, 24) . Whereas myogenin stimulates myocyte development, transcriptional regulator PR domain zinc finger protein 16 (Prdm16) regulates the developmental switch to brown adipocytes. PRDM16 forms a transcriptional complex with activated transcription factor CCAAT/ enhancer-binding protein b, which enables the switch from a myogenic precursor to a brown adipocyte (25) . This in turn leads to the expression of peroxisome proliferator-activated receptor g (Pparg) and Pgc-1a, which are key regulators of brown adipocyte differentiation, and BAT-associated genes such as Ucp1, Cidea, Cox7a1, Cox8b, Elovl3, and Cpt1b. PPARg itself can stimulate brown adipocyte differentiation as well. Indeed, continuous treatment with a PPARg agonist, rosiglitazone, enhances brown adipocyte differentiation in vitro (26) . Although the Myf5-expressing precursors were assumed to be precursors of brown adipocytes and muscle cells only, recent lineage studies contradict this. It was found that Myf5 + precursor cells can also give rise to unilocular white adipocytes in subcutaneous and retroperitoneal WAT (21, (27) (28) (29) . In classic myogenic transcription, Myf5 is thought to function downstream or simultaneously with paired box 3 (Pax3) and upstream of myogenic differentiation 1 (MyoD1). Indeed, expression of Myf5 and Pax3, not MyoD1, overlaps in adipocyte progenitors. This holds true for most adipose tissue depots but not in perigonadal WAT, indicating depot and sex differences (28) . Although all brown adipocytes in interscapular BAT descend from Myf5 + precursors, only a subset of classic brown adipocytes in cervical and no brown adipocytes in perirenal or periaortic BAT could Sites of BAT deposits in humans and mice. Human newborns have a distinct interscapular depot of BAT that regresses with age. Human adults have supraclavicular BAT and BAT depots in the neck region. Smaller depots can also be found along the aorta, vertebrae, and kidneys. BAT is found at different locations in mice. Cervical BAT is located underneath the muscles running from the back of the head to the interscapular area. Ventrolateral of the scapulae is an axillary BAT depot. The major BAT depot is found interscapular. BAT is prominent around the aorta and the hilum of the kidneys.
be traced back to a Myf5 + precursor, suggesting a large heterogeneity within and between adipose tissue depots (28) . Other markers for committed brown adipocyte precursors that differentiate into mature brown adipocytes are early B-cell factor 2 and platelet-derived growth factor receptor a (PDGFRa) (Fig. 3) (30) .
Beige cells are present within WAT and, when present in sufficient quantity, increase energy expenditure and thereby are thought to contribute to a reduction in body fat (31) (32) (33) (34) . In mice, cold exposure and b-adrenergic receptor agonist treatment increase Ucp1 gene expression and mitochondrial biogenesis in WAT, which increases the presence of beige cells within WAT (35) . Beige cells are mostly present in subcutaneous WAT. Adipocyte-specific PRDM16 transgenic mice are able to induce the development of beige cells in subcutaneous WAT and have an increased energy expenditure, are resistant to weight gain, and show improved glucose tolerance on a high-fat diet (HFD) (36) . Other stimuli that can induce beige adipogenesis include noradrenaline (5, 37), lactate (38) , irisin (39) , fibroblast growth factor 21 (40) , bone morphogenetic protein 4 (41), and bone morphogenetic protein 7 (42) .
Beige adipocytes arise from white (i.e., unilocular and Ucp1-negative) adipocytes via transdifferentiation. The transdifferentiation hypothesis is based on experiments in rodents in which beige adipogenesis was induced and examined by microscopy (33, 43, 44) , analysis of DNA content, and labeling with bromodeoxyuridine (32, 45, 46) and UCP1-Cre reporter mice, which allows inducible permanent labeling of Ucp1 + cells and tracing of white, beige, and brown adipocytes (47) . However, other studies show that beige adipocytes can arise de novo from specific precursor cells. These studies use AdipoChaser mice, which have an inducible adipocyte-tagging system with an adiponectin promoter-driven tetracycline-on transcription factor, a tetracycline-responsive Cre (activated by doxycycline), and a Rosa26 promoter-driven loxP-stop-loxPb-galactosidase. Upon doxycycline treatment, all adipocytes become positive for b-galactosidase. Upon induction of beige adipogenesis by cold exposure or b 3 -adrenergic receptor agonist treatment, b-galactosidase-negative beige adipocytes appear in subcutaneous WAT (48, 49) . As in interscapular BAT, Ebf2 expression marks beige adipocytes, regardless of their developmental origin (30) (Fig. 3) . These discrepant insights might result from technical restraints or the fact that transdifferentiation and de novo adipogenesis occur simultaneously, maybe depending on whether adipocytes have experienced beige stimuli before (47) . Formerly beige, dedifferentiated white adipocytes might be capable of transdifferentiation into beige adipocytes, whereas a first encounter with beige stimuli induces de novo development. Alternatively, preencoded beige adipocytes may exist disguised as white adipocytes and only develop their beige phenotype upon the adequate stimuli.
The vasculature may be another important mediator of beiging, as BAT is highly vascularized to enable a fast supply of oxygen and nutrients and transport of generated heat (50) . In WAT, exercise, as well as treatment with a b 3 -adrenergic receptor agonist or a PPARg ligand such as rosiglitazone, not only induces beiging but also increases angiogenesis. Overexpression of Vascular endothelial growth factor (Vegf) increases WAT vascularization and induces increased gene expression of Ucp1 and Pgc-1a in retroperitoneal WAT (51). Cold activates the hypothalamus in the brain, which activates the sympathetic nervous system and results in the release of noradrenaline that binds to b-adrenergic receptors on brown adipocytes. The acute result is intracellular lipolysis, degradation of fatty acids via beta-oxidation, and activation of UCP1. Other effects of activated b-adrenergic receptors occur via cAMP, protein kinase A, cAMP-response element binding protein, and p38 mitogen-activated protein kinase. Oxidative phosphorylation in mitochondria drives protons from the mitochondrial matrix into the intermembrane space, generating an electrochemical gradient by which protons flow back into the mitochondrial matrix via ATP synthase, activating ATP synthesis in, for example, heart and skeletal muscle. In brown adipocytes, UCP1 is found on the inner-mitochondrial membrane, where it causes mitochondrial uncoupling. UCP1 increases the permeability of the inner mitochondrial membrane and thus causes a reflux of protons into the mitochondrial matrix, bypassing ATP synthase. This proton leakage leads to dissipation of energy into heat. ADP, adenosine diphosphate; cAMP, cyclic adenosine monophosphate; Creb, cAMP-response element binding protein; FFA, free fatty acid; p38, p38 mitogen-activated protein kinase; PKA, protein kinase A; SNS, sympathetic nervous system. doi: 10.1210/er.2016-1066 press.endocrine.org/journal/edrv
The importance of VEGF as an essential downstream target in the process of beiging was further confirmed by administration of an anti-VEGF antibody, which reduced both angiogenesis and beiging in WAT (51) . Contrary to beiging of WAT, whitening of BAT also occurs. Sympathetic denervation, thermoneutrality, aging, and excessive energy supplies in obesity cause BAT to accumulate lipid droplets, resulting in whitening of the tissue (52, 53) . This is accompanied by decreased vascularization, hypoxia, and mitochondrial dysfunction. A whitened phenotype of BAT in obesity is therefore predictive of decreased BAT activity and is associated with complications such as insulin resistance (50) . Although the mechanisms of BAT whitening are largely unknown, VEGF-mediated vascularization seems to play an important role; obesity reduces Vegf expression, and deletion of Vegf in adipose tissue results in whitened BAT (50).
C. BAT activity and obesity: what we have learned from mouse models Much of our current knowledge on the role of BAT in obesity is derived from experimental animal studies, often including genetically modified mice that were subjected to different models of obesity. In these studies, decreased BAT activity was associated with aggravated metabolic dysfunction and an increase in obesity, whereas increased BAT activity was associated with improved metabolism.
Over the years, several experimental animal studies have been published in which the relation between obesity and BAT was studied (Table 1) . BAT activity is 
Pax3
+ expressing precursor population. When these precursors are exposed to myogenin, they will develop into myocytes. PRDM16 and PPARg promote brown adipocyte differentiation. Brown adipocytes in BAT can undergo whitening upon exposure to thermoneutrality, obesity, aging, or sympathetic denervation. EBF2, early B-cell factor 2; Myf5, myogenic factor 5; MyoD1, myogenic differentiation 1; Pax3, paired box 3. press.endocrine.org/journal/edrvdependent on environmental temperature, and therefore, housing temperature has major metabolic consequences. Mice housed at room temperature (18-22°C) are thermally stressed, leading to increased metabolism and activated BAT to maintain their body temperature. Elimination of thermal stress is accomplished by thermoneutral housing conditions of 30°C. It is important to realize that in some experimental setups, it is thus appropriate to house mice under thermoneutral conditions, for example, when comparing studies to thermoneutral conditions in humans (i.e., 25°C) or to distinguish central mediated effects from direct activation of BAT.
Genetic models of decreased BAT activity
Energy expenditure and heat production in BAT occur via UCP1, and mice lacking UCP1 are indeed unable to maintain their body temperature when exposed to acute cold. However, at room temperature, this decreased ability to dissipate energy into heat does not result in increased obesity on chow or HFD feeding (54), but UCP1 knockout mice are more susceptible to develop obesity with age (55) . Strikingly, when UCP1 knockout mice are housed under thermoneutral conditions (30°C), they do develop more severe obesity on a HFD and also gain slightly more weight when on a chow diet (56) .
Other studies in mice have revealed that besides UCP1 deficiency, additional models with decreased BAT activity also suffer from cold intolerance and display an obesity-sensitive phenotype, as listed in Table 1 . Genetic ablation of BAT function via expression of a diphtheria toxin A-chain driven by regulatory elements of the Ucp1 gene decreased the UCP1 content in BAT, which resulted in a reduction in nonshivering thermogenesis and obesity. Consequently, these mice did not show a thermogenic response upon treatment with a b 3 -adrenergic receptor agonist (57) . b-Adrenergic receptor knockout mice lacking all 3 known b-adrenergic receptors, as well as dopamine b-hydroxylase-deficient mice, which fail to convert dopamine into noradrenaline, both present inactive BAT and are sensitive to cold (58, 59) . Furthermore, b-adrenergic receptor knockout mice are slightly obese on a low-fat diet and develop massive obesity on an HFD (59) . Leptin-deficient ob/ob mice also have reduced Ucp1 expression in BAT and, similar to UCP1 knockout mice, are cold sensitive but will survive when they are gradually exposed to extreme cold (4°C). However, mice lacking both UCP1 and leptin do not survive temperatures below 12°C. These models show that alternative mechanisms for maintaining body temperatures do exist but that these are only effective within certain limits (60) .
Increasing BAT activity improves metabolism in mice
The disruption of BAT activation results in an obesityprone phenotype in mice. Conversely, increasing the amount and/or function of BAT can induce a healthy metabolic phenotype. Cold exposure and b 3 -adrenergic receptor agonist treatment increase Ucp1 expression, mitochondrial biogenesis, and differentiation of brown adipocytes. This results in BAT hyperplasia and an increased thermogenic capacity, ultimately leading to a reduction in body weight (34, 43, 63, 66, 85) . BAT activation also increases the influx of nutrients into brown adipocytes, including glucose and fatty acids. Glucose is taken up by glucose transporter 1/4 receptors (86, 87) and (triglyceride-derived) fatty acids by CD36 and lipoprotein lipase (LPL) (64) , which is regulated by Angptl4 (88) . Whether BAT takes up triglyceride-rich lipoprotein (TRL)-derived fatty acids by holoparticle uptake of TRL or after lipolysis of TRLs is under debate (89), although current evidence points to uptake of fatty acids derived from triglycerides after lipolysis (90) . By taking up substrates, BAT activation leads to lowering of plasma glucose and triglyceride levels and can even attenuate hypercholesterolemia by indirectly enhancing hepatic clearance of TRL remnants (35, 89). Whereas UCP1 knockout mice are more prone to develop obesity, constitutive overexpression of UCP1 in adipocytes prevents obesity in mice (67) ( Table 1) . Transgenic mice with adipocyte-specific overexpression of winged helix/forkhead transcription factor C2 (Foxc2), which plays a regulatory role in adipocyte metabolism, have an enhanced sensitivity of the b-adrenergic/cAMP/protein kinase A pathway and an increased expression of Ucp1. These mice develop adiposity and display improved glucose tolerance following an HFD compared with wild-type mice (68, 69) . BAT mitochondria express high levels of cell death activator CIDE-A (Cidea), which also plays a role in energy homeostasis. Mice deficient for CIDE-A have an increased amount of BAT and are protected from diet-induced obesity (DIO) (70) . Loss of Cidea stabilizes the AMPactivated protein kinase (AMPK) complex, which enhances basal AMPK activity, leading to elevated fatty acid oxidation and energy expenditure (91) . In line with this, treatment of mice with the AMPK activator metformin enhances BAT activity (92) . Fatty acid binding proteins are also largely involved in energy metabolism. Mice with mutations in 2 related adipocyte fatty acidbinding proteins (FABPs), aP2 and mal1, are protected from DIO and exhibit increased energy expenditure (93) . Moreover, FABP4/5 knockout mice have a severely impaired thermogenesis during fasting due to the depletion of energy storage and reduced energy supply in BAT and skeletal muscle (61) . Three research groups have been able to increase the amount of BAT by successfully transplanting BAT in diabetic or obese mice and observed a reversal of their obese phenotype (71) (72) (73) . These studies thus suggest that increasing BAT activity has a great potential as a treatment to reverse obesity.
BAT activation and atherosclerosis
An interesting therapeutic effect of activating BAT includes the reduction of dyslipidemia-associated atherosclerosis. In APOE*3-Leiden.CETP mice, which have a human-like lipoprotein metabolism through expression of a mutated variant of the human APOE*3 gene combined with human cholesteryl ester transfer protein, BAT activation by b 3 -adrenergic receptor stimulation was shown to be protective against dietinduced atherosclerosis (35) . b 3 -Adrenergic receptor agonist treatment decreased plasma triglyceride and cholesterol levels (35) . Notably, using ApoE knockout or low-density lipoprotein receptor (LDLR) knockout mice, b 3 -adrenergic receptor agonist treatment similarly reduced plasma triglycerides but did not affect plasma cholesterol levels or atherosclerosis (35) . In fact, cold exposure of ApoE knockout or LDLR knockout mice increased plasma levels of small lowdensity lipoprotein remnants, leading to unfavorable plasma lipid levels and even accelerated development of atherosclerotic lesions (65) . These findings show that in the presence of an intact ApoE-LDLR clearance pathway, as is present in APOE*3-Leiden.CETP mice, BAT-mediated local lipolysis of triglyceride-rich lipoproteins stimulates the hepatic clearance of lipoprotein remnants via ApoE and the LDLR. As a result, BAT activation reduces atherosclerotic lesion size and severity in APOE*3-Leiden.CETP mice but not in mice lacking ApoE or the LDLR (35) .
III. BAT and Obesity in Humans
A. Presence of active BAT in human adults
In humans, BAT was initially considered to be only present in newborns but was recently detected to be still present in adults as well (9, 94, 95) . Simultaneous examinations of positron-emission tomographic (PET) and X-ray computed tomography (CT) revealed sites in human adult adipose tissue with increased 18 F-fluorodeoxyglucose (FDG) uptake, indicating metabolically active tissue. Tissue biopsy specimens confirmed that the FDGintense tissue was indeed composed of brown adipocytes and thus could be classified as BAT (95) . In humans, cold exposure increases glucose uptake rate in BAT by 12-to 15-fold compared with thermoneutral conditions (95, 96) . This was reflected by an increased FDG uptake, as well as by an increased fatty acid uptake and a higher activation of oxidative metabolism, which was demonstrated by subsequent studies in which humans were subjected to cold (95, 97) . The b-adrenergic blocker propranolol reduces uptake of FDG in BAT depots in humans (98) , and treatment with mirabegron, a b 3 -adrenergic receptor agonist approved to treat the overactive bladder, increases the metabolic activity of BAT, evidenced by increased FDG uptake in healthy male participants (99) .
Studies in humans comparing gene expression profiles of white, beige, and brown adipocytes claim that BAT in adult humans is mainly composed of beige adipocytes (21-23, 100, 101), whereas others have found markers for classic BAT in humans (102) . Controversy exists on brown and beige markers, and further studies will be needed to unequivocally characterize BAT in humans. Other discrepancies can be caused by sampling bias (i.e., variations in location where the biopsies were taken) and differences in age or BMI of the studied population. It is likely that beige adipocytes remain present in the adult state when hypothermia is a less frequent threat than in newborns or rodents. The capability of beige cells to switch between a state of energy storage and energy press.endocrine.org/journal/edrvdissipation is intriguing, and further studies on how this switch works are needed.
B. BAT activity and obesity
Along with the discovery of BAT in adult humans by PET/CT studies, it also became clear that the presence of BAT, visualized through FDG uptake, showed a negative correlation with BMI and body fat percentage (9, 94) . A study of 2000 randomly selected PET/CT scans showed a higher frequency of functionally active BAT in females than in males and a negative correlation with age, BMI, but also beta-blocker use, outdoor temperature at the time of the scan, and season (103, 104) . Interestingly, recent data show that cold-induced fatty acid uptake by BAT is similar in individuals with type 2 diabetes, agematched controls, and healthy young controls (105) , suggesting that previous conclusions based on FDG uptake may also reflect altered insulin sensitivity of BAT rather than BAT activity.
Because stimulating BAT results in enhanced energy expenditure, it is an intriguing target for the control of whole-body energy balance, adiposity, and obesity. The first indication that BAT activity could be increased in humans was shown in a PET/CT study, where 10 morbidly obese patients with a mean BMI of 42 kg/m 2 were scanned before and 1 year after bariatric surgery. Before surgery, FDG uptake by BAT was seen in only 2 patients, whereas 1 year after surgery, when the mean BMI was 30 kg/m 2 , active BAT was present in 5 patients (106). Interestingly, also repeated cold exposure can increase BAT activity in humans. Successful cold acclimation protocols include 6 hours of cold exposure for 10 consecutive days or daily exposure (17°C) for 2 hours during 6 weeks (2, 107). Using these protocols, it was possible to increase BAT volume by 37% or increase FDG uptake by 60% and decrease fat mass in humans (2) .
Although still scarce, more and more studies on human brown or beige adipocyte development, function, and how they are modulated are published. Min et al. (108) reported that proangiogenic factors drive the proliferation of human beige adipocyte progenitors and activate beige adipocytes, which, when transplanted in mice, improves systemic glucose turnover. Accordingly, human individuals with a higher abundance of BAT have lower blood glucose levels, and glucose uptake in BAT is associated with improvements in systemic glucose homeostasis and insulin sensitivity (109, 110) . Increased supraclavicular BAT activity in humans is inversely associated with arterial inflammation and reduced risk of cardiovascular events (111) . Interestingly, South Asians have a higher prevalence of hyperglycemia, dyslipidemia, and cardiovascular disease and a lower amount of BAT (112) . Glucose uptake by BAT in humans is associated with heat production following a circadian rhythm in which BAT may buffer glucose fluctuations and maintain whole-body glucose homeostasis over time (113) . In another study, 48 to 60 hours of fasting induced insulin resistance resulted in a considerable decrease in BAT glucose uptake and nonshivering thermogenesis during cold stimulation (114) . The effects of antiobesity treatments on human BAT have not been studied in detail, but mouse studies suggest a mechanism mediated by BAT for some treatments. Compounds used in humans to improve dyslipidemia and hyperglycemia and/or lower plasma triglyceride levels, such as metformin, rimonabant, salsalate, and activation of the glucagon-like peptide 1 receptor, all activate BAT in mice (92, (115) (116) (117) .
IV. Chronic Low-Grade Inflammation in Obesity
A. Dysfunctional adipocytes in WAT attract immune cells
In obesity, excessive energy intake is accompanied by an increased storage of lipids in adipose tissues, leading to hypertrophy of adipocytes, hypoxia, and cell death, causing WAT dysfunction and fibrosis. Dysfunctional adipocytes change the local microenvironment with leakage of fatty acids and other products resulting from adipocyte cell death. This causes a release of adipokines, chemokines, and cytokines by WAT and subsequent recruitment of inflammatory cells (118, 119) . The chronic nature of obesity affects steady-state homeostasis and leads to continuous activation of the immune system (118) . Due to the extensive communication between adipocytes and immune cells, chronic inflammation disturbs the homeostatic regulation of insulin signaling and adipogenesis in white adipocytes, leading to reduced insulin sensitivity and development of type 2 diabetes (118, 120) . Thus, by increasing circulating cytokines and attracting immune cells, WAT contributes to metabolic dysfunction.
B. Inflammation in obese white adipose tissue
Myeloid cell recruitment into WAT
The first proof that inflammation is important in the pathogenesis of obesity and the resulting metabolic dysfunction was provided by Hotamasligil et al. (121) . The proinflammatory cytokine tumor necrosis factor a (TNF) was found to be present in WAT and correlated with insulin resistance in humans and mice (121) . It became evident that the infiltration of proinflammatory macrophages in WAT plays a central role in the inflammatory response as a dominant source of TNF (122) . In WAT of lean mice, 10% to 15% of the cells are macrophages, whereas obese WAT contains 45% to 60% macrophages (122) . Resident macrophages in lean WAT have a predominant anti-inflammatory phenotype, whereas in obesity, inflammatory Ly6C high CCR2
+ monocytes are recruited to WAT, where they differentiate, acquire a proinflammatory or M1 phenotype, and form the majority of macrophages (120, (122) (123) (124) (125) (126) (127) . Antiinflammatory or M2 macrophages depend on the cytokines interleukin 4 (IL) 4 and IL-13 and require signal transducer and activator of transcription (STAT) to maintain their alternative activation state (6) . Other myeloid cells that play a role in WAT include neutrophils and eosinophils. Neutrophils are very short-lived cells that are already present in WAT within 3 days of HFD (128, 129) . In contrast, the amount of eosinophils is inversely correlated with adiposity, and exhaustion of eosinophils in mice results in increased body weight, glucose intolerance, and insulin resistance (130) . Both type 2 innate lymphoid cells (ILC2s) and eosinophils have only recently been shown to be an important cell population in WAT and are a predominant source of IL-4 and IL-13, the cytokines required for the induction of M2 macrophage polarization (130, 131) . but both populations increase drastically in an obese state, whereas CD4 + Tregs decrease (133) . Similarly, as the ratio between M1 and M2 macrophages increases in obese WAT, the Th1 and Th2 T-cell ratio does as well. This results in a decrease in Th2-derived cytokines such as IL-4 and IL-13, thereby reducing M2 macrophage polarization. An increase in Th1 T cells and cytotoxic T cells results in excessive secretion of TNF and interferon g (IFNg), which polarizes macrophages to a proinflammatory state, resulting in increased inflammation in obese WAT (130, (134) (135) (136) . The chronic low-grade inflammation in obese WAT also includes the recruitment of B cells, natural killer cells, and mast cells (137, 138) . Natural killer cells are activated by recognition of lipid antigens, and mast cells contain granules that can release a variety of mediators, including histamine, serotonin, and cytokines, which also promote recruitment of inflammatory cell types (139) .
Overall, a variety of immune cells infiltrate WAT in DIO, inducing a switch from a homeostatic antiinflammatory environment to a state of chronic lowgrade inflammation.
C. The immune system in brown and beige adipose tissue
In contrast to the established role of the different immune cells in WAT, the contribution of the immune system to the development, function, and activity of BAT is still largely unknown. However, we do know that obese individuals have a decreased amount of active BAT, based on FDG uptake, which is related to their low-grade inflammatory state. Moreover, an inactive brown adipocyte accumulates lipids, similar to a white adipocyte, and ablation of noradrenergic input by selective sympathetic denervation of BAT indeed results in a "whitened" appearance of brown adipocytes with large intracellular vacuoles (53) . Because the recruitment of macrophages into WAT is correlated with lipolysis of stored triglycerides (120) , it is likely that release of fatty acids also induces recruitment of immune cells in BAT. However, whether this is indeed the case is still unknown.
In DIO, thermoneutral housing leads to an additive increase in inflammation in white adipose tissue and in the vasculature compared with normal housing conditions. Although not causing increased insulin resistance, the increase in vascular inflammation does cause enhanced progression of atherosclerosis (140) , indicating that BAT protects against obesity-induced atherosclerosis. In another study, a similar phenomenon was observed. Immune-compromised C57Bl/6 nude mice experience cold stress when housed at 23°C, which modulates energy and body weight homeostasis, and are therefore protected from DIO. However, at thermoneutrality (33°C), they do develop DIO with increased adiposity, hepatic triglyceride accumulation, increased inflammatory markers, and glucose intolerance (141) , showing that BAT activity protects against metabolic disarray and adipose tissue inflammation.
Besides environmental temperature, other incentives such as the biological clock (53, 142) , hormones (143, 144) , and food intake not only modulate energy expenditure via the hypothalamus but also affect inflammation. For instance, time-restricted feeding of an HFD for 8 hours per day increases BAT activity and reduces adipocyte hypertrophy and inflammation in WAT compared with ad libitum HFD-fed mice (145) . Gut hormones such as glucagon-like peptide 1 (GLP-1) mediate effects on food intake, energy expenditure, and inflammation. GLP-1 receptor signaling activates BAT and promotes beiging of WAT (117, 146) , whereas GLP-1 also reduces macrophage infiltration and inflammatory signaling in white adipocytes and macrophages (147, 148) . Other hormonal changes such as menopause also affect energy metabolism. Estradiol inhibits AMPK in the hypothalamus, which activates thermogenesis in BAT (143) . Indeed, ovariectomized mice with reduced estradiol levels gain more weight than sham operated mice and press.endocrine.org/journal/edrvhave reduced energy expenditure and increased WAT inflammation (144) . Currently, many other factors that affect both BAT activity and inflammation, such as p53 (74) and upstream stimulatory factor 1 (75), are being investigated ( Table 1) . As described below, reports have also provided evidence that immune cells are directly involved in regulating the activity of brown as well as beige adipocytes.
Inflammatory mediators in BAT
Remarkably, Roberts-Toler et al. (76) discovered that feeding mice an HFD for 16 weeks not only reduced insulin signaling but also increased messenger RNA (mRNA) levels of markers of inflammation in both WAT and BAT, including Tnf and the macrophage marker F4/ 80. Microarrays of interscapular BAT showed an upregulation of immune response gene networks after 24 weeks of HFD, including genes that indicate infiltration of leukocytes, monocytes, and macrophages (CD44, CD52, CD68, and CD84). Furthermore, after 2, 4, and 8 weeks of HFD, immune gene networks were upregulated, including genes responsive to IFNg, immunity-related GTPase family M member 2 (Irgm2), guanylate binding protein 4 (Gbp4), and interferon gamma induced GTPase (Igtp) (149) . These gene expression profiles hint toward the presence of immune cell trafficking, leukocyte activation, and lymphocyte activation in BAT.
In another study, gene expression analysis in BAT of obese mice showed an upregulation of genes encoding the inflammatory cytokines TNF, IL-6, CCL2, and CCL5 (150) . Furthermore, activation of the pattern recognition receptors, nucleotide-oligomerization domain-containing protein 1, Toll-like receptor (TLR) 2, and TLR4 in brown adipocytes induces a proinflammatory response through nuclear factor-kB and mitogen-activated protein kinase signaling pathways. Pattern recognition receptors are responsible for the sensing of invading pathogens and can activate specific signaling pathways leading to distinct inflammatory responses. Enhanced pattern recognition receptor expression decreased UCP1 expression as well as mitochondrial respiration in brown adipocytes (150) .
Another factor affecting BAT function and BAT inflammation is p62, a protein involved in cell growth and differentiation, energy metabolism, and inflammation. Global ablation, as well as adipocyte specific ablation of p62, results in obesity and insulin resistance. Moreover, these mice have decreased nonshivering thermogenesis and a lower metabolic rate, which is caused by impaired mitochondrial function in brown adipocytes, due to decreased activation of p38a mitogen-activated protein kinase and its downstream regulators of thermogenesis, including UCP1, PGC-1a, and cAMP-response element binding protein. Furthermore, gene expression of obese BAT in adipocyte-specific p62-deficient mice reveals induction of pathways of inflammation and increased macrophage infiltration in BAT (62) ( Table 1) .
BAT activation and beiging of WAT: role of the immune system
Macrophages have been shown to play a role in adaptive thermogenesis. Nguyen et al. (3) demonstrated that short-term (6-hour) cold exposure increases M2 macrophage markers in both WAT and interscapular BAT in mice. Furthermore, absence of M2 macrophages blunts BAT activity and induces cold intolerance in DIO mice. Acute cold exposure stimulates anti-inflammatory M2 macrophages to produce tyrosine hydroxylase (TH), a catecholamine-synthesizing enzyme, via IL-4-STAT6 signaling. This results in the release of noradrenaline, which binds to the b 3 -adrenergic receptor on the brown adipocyte membrane. Consequently, BAT is activated, evidenced by the induction of Ucp1 and other thermogenic gene expression, such as Pgc-1a and acylCoA synthase long-chain family member 1 (Acsl1). An acute cold-induced increase of M2 macrophages in BAT and WAT was not observed in Il-4/Il-13 and Stat6 knockout mice, indicating that the IL-4/IL-13-STAT6 pathway is crucial to increase the amount of M2 macrophages in interscapular BAT after a cold challenge (3). However, other reports show that upon prolonged, 72-hour cold exposure, depletion of macrophages by clodronate or deficiency of CCR2 does not affect adaptive thermogenesis in classic BAT but induces beiging of WAT. This suggests a less pronounced role for macrophages in adaptive thermogenesis in BAT but rather an involvement in beiging of WAT. Especially M2 macrophages have been shown to induce beiging of subcutaneous WAT. Impaired monocyte recruitment in CCR2 knockout mice results in decreased biogenesis of beige adipocytes upon cold exposure, proving that CCR2 is responsible for cold-induced monocyte recruitment (5). Moreover, beiging of WAT is also observed when M1 to M2 polarization is enhanced through lowering of receptor interacting protein 140 (151) .
Not only can macrophages produce TH, but they are also capable of producing the catecholamine noradrenaline (152, 153) and express b 2 -adrenergic receptors. Binding of noradrenaline to b 2 -adrenergic receptors promotes M2 polarization, enabling a paracrine loop and suggesting autoregulation of catecholamine levels (154) . Protein expression of the catecholamine-producing enzyme TH increases upon cold exposure in BAT as well as subcutaneous WAT and epididymal WAT (5). Interestingly, myeloid-specific TH-deficient mice have impaired cold-induced biogenesis of beige adipocytes but exhibit normal BAT activity. BAT is highly innervated by the sympathetic nervous system, along with a constitutively high expression of catecholamine-synthesizing enzymes. The contribution of noradrenaline production by macrophages may therefore be less crucial in BAT than in the far less innervated WAT, which has a low basal TH expression (5) .
Cold-induced remodeling of subcutaneous WAT into thermogenic beige fat by noradrenaline-producing macrophages was shown to be induced by eosinophils, via IL-4, IL-13, and STAT6 (5) . Mouse models with a genetic loss of Il-4/Il-13, Il-4Ra, Stat6, or IL-4-producing eosinophils have impaired cold-induced biogenesis of beige adipocytes. In addition, administration of IL-4 into DIO mice at thermoneutrality reduces body weight, improves insulin sensitivity, and increases protein expression of UCP1 in subcutaneous WAT but not in classic interscapular BAT (5). Meteorin-like hormone was found to be responsible for inducing IL-4 secretion by eosinophils (37) . Meteorin-like hormone is a target of PGC-1a4 and is released by skeletal muscle during exercise and by adipose tissue upon cold exposure. It does not have a direct effect on brown adipocytes but stimulates eosinophils to produce IL-4, which promotes activation of M2 macrophages and causes the increased expression of thermogenic and anti-inflammatory gene programs (37) .
Besides macrophages, ILC2s are important mediators of beiging of WAT (Fig. 4) . This subtype of innate lymphoid cells controls eosinophil and M2 macrophage responses by secreting IL-5 and IL-13, initiates type 2 immune responses, and is designed to protect against helminth infections but also promote allergies (155) . In humans and mice that are obese, decreased numbers of ILC2s have been detected in subcutaneous WAT (6) . The cytokine IL-33 is critical for the maintenance of ILC2s, and experimental mouse studies have shown that IL-33 limits the development of spontaneous obesity. IL-33-deficient mice gain more weight on an HFD, have a reduced number of ILC2s, and exhibit decreased numbers of beige adipocytes in WAT. Administration of IL-33 increases numbers of ILC2s and eosinophils in subcutaneous WAT, leading to increased energy expenditure in mice by inducing beiging of WAT (4, 6). IL-33-induced beiging is a result of proliferation and differentiation of PDGFRa + adipocyte precursor cells. PDGFRa + preadipocytes do not express receptors required for signaling by IL-33 (IL1RL1) or IL-5 (IL-5Ra), but they do express IL-4Ra, which is required for both IL-4 and IL-13 signaling (4). Therefore, beiging of WAT is also dependent ) demonstrated that beige adipocytes can also develop via an alternative mechanism, independently of IL-4, IL-13, eosinophils, or macrophages. DblGata1 knockout mice, which lack eosinophils; IL-4Ra knockout mice, which do not have IL-4 and IL-13 signaling; or ILC2-sufficient Rag2 knockout mice, which lack mature lymphocytes but have reconstituted ILC2s still exhibit beiging of WAT, although all factors combined most likely contribute to optimal beiging. ILC2s produce an opioid-like peptide, methionine-enkephalin (MetEnk) peptide, which upregulates UCP1 in subcutaneous WAT and induces beiging of adipocytes without affecting IL-4 or IL-13 levels or the number of eosinophils or macrophages in WAT (6). This mechanism was only restricted to subcutaneous WAT. MetEnk receptors MetEnk receptor d1 opioid receptor (Oprd1) and MetEtnk receptor opioid growth factor receptor (Ogfr) were differentially expressed in WAT and BAT, explaining these tissue-specific effects (6).
These 2 different mechanisms as to how ILC2s control beiging of WAT; PDGFRa + adipocyte precursor cell proliferation and differentiation and MetEnk production might synergize in the generation of beige adipocytes. The previously unrecognized feature of ILC2s to produce MetEnk would need to be confirmed in future studies, as well as the role for beige adipocyte precursors. Further studies are needed to determine the relative contribution of IL-4, IL-13, and MetEnk to beige adipogenesis. It would also be interesting to determine the source of IL-33 production, the cytokine that puts the ILC2 pathway in motion. Improved metabolic health by caloric restriction in mice also indicates that type 2 cytokine signaling is important in beiging of WAT. Caloric restriction increases the amount of eosinophils, type 2 cytokines, and M2 macrophages in WAT but does not affect the number of ILC2s and consequently promotes beiging. The development of beige adipocytes upon caloric restriction is ablated in Stat6 knockout and IL4R knockout mice, suggesting that type 2 cytokines play an important role in beiging of WAT (158) .
TLRs respond to various pathogen-associated molecules, including saturated fatty acids, by inducing signal transduction and transcription of various chemokines and cytokines, and are predominantly found on cells of the innate immune system. However, adipocytes also express several TLRs (TLR3 and TLR4) and contain relevant downstream signaling elements. Members of the interferon regulatory factor (IRF) family regulate both immune cell activation as well as adipocyte differentiation, via TLR3 and TLR4. HFD-fed IRF3-deficient mice have improved insulin sensitivity, reduced adipose and systemic inflammation, and enhanced beiging of subcutaneous WAT (159) . TLR4 activation in obesity or by lipopolysaccharide indeed suppresses beiging of subcutaneous WAT and causes defective BAT. In human primary white adipocytes, TLR4 activation by lipopolysaccharide (LPS) suppresses UCP1 induction (160) .
Irf4
flox/flox ;UCP1-Cre mice, lacking IRF4 specifically in UCP1-positive cells, are more obese on an HFD. IRF4 is induced by cold, promotes energy expenditure, and increases thermogenic gene expression, including PGC-1a and PRDM16 (161) . IRF4 was also shown to be a key transcription factor in controlling M2 polarization (162) . These data indicate that TLRs in both immune cells and adipocytes play a role in adaptive thermogenesis.
The circuit in which metabolic improvements are associated with beige adipogenesis and mediated by eosinophils, type 2 cytokines, and M2 macrophages is also linked with the status of the gut microbiome (80) . Germfree mice or mice with antibiotic-depleted microbiota have more beige adipocytes in both lean and obese WAT, leading to improved glucose tolerance and insulin sensitivity mediated by eosinophils, type 2 cytokines, and M2 macrophages (80) . Cold exposure alters the gut microbiota by remodeling of the intestine and adipose tissue, increasing the absorptive surface of the gut. Transfer of cold-adapted microbiota improves insulin sensitivity and enhances beiging of WAT (81) . With the current high prevalence of human obesity and the frequent use of antibiotics, the relation between beiging and microbiome is an interesting topic of future research.
Another player related to beiging of WAT by M2 macrophages is adiponectin, an adipokine regulating glucose levels and fatty acid degradation. Adiponectin can promote the polarization of macrophages toward an M2 phenotype, correcting obesity-induced macrophage infiltration and inflammation. Hui et al. (79) show that cold exposure induces elevated gene expression and protein levels of adiponectin in subcutaneous WAT and, using adiponectin knockout mice, show that adiponectin is essential for beiging of the subcutaneous adipose tissue via M2 macrophage proliferation. Adiponectin deficiency has no effect on ILC2s or type 2 cytokines, suggesting that these are not the downstream effectors of adiponectin during cold-induced beiging (79) .
Increased numbers of M1 macrophages in obese WAT suppress cold-induced beiging of subcutaneous WAT in mice. Depletion of macrophages, using clodronate liposomes, eliminates the suppressive effects of M1 macrophages on UCP1 induction and reduces the level of TNF in obese WAT. Cold exposure in clodronate-treated obese mice has metabolic benefits, such as lower body weight and decreased plasma glucose levels. Mitochondrial biogenesis is not the underlying mechanism by which M1 macrophages suppress UCP1 because this was not affected by clodronate or intraperitoneal TNF injections (82) .
Interestingly, IL-33 also increases the percentage of Tregs in WAT, the T-cell fraction contributing to glucose homeostasis (6). Medrikova et al. (78) performed a microarray on sorted Tregs from BAT and identified a BAT-specific subset of Tregs, which contribute to metabolic control of BAT. Upon depletion of Tregs, the tissue exerted an increased inflammatory state with an increase in macrophages, resulting in mice that were more sensitive to cold (78) . However, nude mice on a C57Bl/6 background, which lack mature T cells, experience cold stress at 23°C and are protected from DIO by increased thermogenesis and energy expenditure. This suggests that T cells are not required for adaptive thermogenesis in C57Bl/6 nude mice. At thermoneutrality, C57Bl/6 nude mice are susceptible to DIO and associated increased inflammatory markers in adipose tissues (141) .
Cytokines
Besides the effects of IL-4 and IL-33, which induce beiging as described above, other cytokines have also been shown to play a role in thermogenesis. Adipose tissue becomes hypoxic in the development of obesity, which contributes to the inflammatory state and the induction of TNF. This cytokine further affects adipocyte homeostasis by reducing expression of Pgc-1a and Pparg in both white and brown adipocytes (163) . The induction of beige adipocytes in vitro by a b-adrenergic receptor agonist is blunted upon stimulation with TNF or proinflammatory cytokines derived from LPS-activated macrophages. TNF is also involved in apoptosis of brown adipocytes, as shown in TNF receptor-deficient ob/ob mice (164) . Furthermore, TNF impairs mitochondrial biogenesis in WAT, BAT, and muscle of ob/ob and DIO mice and leptin receptor-deficient Zucker fa/fa rats (165). Extracellular signal-related kinase (ERK), which mediates the induction of inflammatory cytokines, has been shown to be an important factor in the suppression of UCP1 transcriptional activation in white adipocytes and activated macrophages (166) . Together, these data indicate that cytokines can also directly influence BAT activity.
Moisan et al. (167) performed a small-molecule screen to find pathways that induce a brown-like thermogenic program in human adipocytes in vitro. They identified tofacitinib and R406, which both target the janus kinase (JAK)-STAT1/3 pathway in adipocytes, with R406 having additional targets, including protein kinase B and extracellular signal-related kinase 1/2. TNF can signal through JAK-STAT and extracellular signal-related kinase pathways, and although TNF represses Ucp1 expression, simultaneous stimulation with TNF and the compounds (partially) restored Ucp1 levels (167) . Furthermore, IFNg treatment reduces Ucp1 expression in human brown adipocytes. Interferons (a/b/g) bind to JAKs and activate STAT1/2/3, and repression of IFN signaling by JAK inhibition contributes to the upregulation of Ucp1 and promotes the metabolic beiging of adipocytes (167) .
Another major cytokine in regulating inflammatory responses in obesity is IL-6, although it is unclear yet whether IL-6 serves a harmful or a protective role. IL-6 has a homeostatic role in limiting inflammation but can also have proinflammatory effects (168) . This leads to controversial results in studies on IL-6 in obesity. Plasma IL-6 levels increase in obesity and correlate with C-reactive protein levels (169) , and infusion of IL-6 immediately impairs insulin sensitivity in mice (170) . However, IL-6 deficiency results in more obese mice (171) but not in all models (172) . Myeloid-specific IL-6R inactivation leads to a greater propensity to develop obesity-induced inflammation and glucose intolerance. IL-6 induces the IL-4 receptor and is therefore an important determinant in M2 macrophage polarization (168) . With respect to BAT, IL-6-deficient mice have reduced energy expenditure and fatty acid oxidation at room temperature. Housed at 4°C, IL-6-deficient mice have a lower core body temperature than wild type mice (173) . Knudsen et al. (83) gave daily intraperitoneal injections of IL-6 for 7 days, which increased Ucp1 mRNA but not UCP1 protein levels in inguinal WAT. Cold exposure increases inguinal WAT Ucp1 mRNA content similarly in IL-6-deficient as wild type mice, whereas exercise training (which induces the release of IL-6 from contracting muscle) increases inguinal WAT Ucp1 mRNA in wild type but not in IL-6-deficient mice. Taken together, the appropriate cytokine stimulation can induce beiging of WAT, which could be a potential mechanism to increase energy expenditure in obesity.
Beiging of WAT is also found in cancer-associated cachexia (wasting syndrome), where b-adrenergic activation doi: 10.1210/er.2016-1066 press.endocrine.org/journal/edrvand/or inflammatory cytokine-induced lipolysis cause WAT atrophy. These beige adipocytes are present within WAT and cause increased lipid mobilization and energy expenditure (77) . The cytokine IL-6 increases Ucp1 expression in WAT, whereas silencing IL-6, an anti-IL-6 antibody, the nonsteroidal anti-inflammatory drug sulindac, or b 3 -adrenergic blockade in mice reduces WAT beiging and ameliorates the severity of cachexia. This is also observed in patients (77) . The involvement of the sympathetic nervous system in BAT also contributes to a homeostatic cytokine environment. Surgical denervation of BAT or b-adrenergic antagonist propranolol treatment upregulates gene expression of Tnf, ll-6, and Ccl2, without a change in F4/80 expression, indicating that the sympathetic nervous system and b-adrenergic signaling are necessary to maintain an anti-inflammatory state in BAT (174) .
Chemokines
Chemokines and chemokine receptors regulate leukocyte influx into obese WAT. Chemokine receptors on immune cells in WAT and serum chemokine levels are increased in obese vs lean individuals (175) . Chemokines secreted by the stromal vascular fraction and/or white adipocytes include CCL5, CCL20, CXCL10, and CXCL12, which promote the accumulation of leukocytes into WAT through binding to their receptors CCR5, CCR6, CXCR3, and CXCR4, respectively (119, 176, 177) .
The regulation of BAT homeostasis and leukocyte influx by chemokines is scarcely studied. DIO adipocyte-specific CXCR4 knockout mice develop severe obesity upon HFD feeding, have an increased proinflammatory leukocyte content in WAT, and exhibit reduced thermogenic capacity when exposed to cold. This reveals that CXCR4 prevents inflammatory leukocyte influx in WAT and that adipocyte Cxcr4 expression is required for the thermogenic capacity of BAT, thereby increasing overall energy expenditure and decreasing susceptibility to DIO (84) .
Lipokines
Besides metabolic effects, lipids have inflammatory signaling properties. Although saturated fatty acids promote adipose tissue inflammation and insulin resistance through TLR signaling (178), n-3 fatty acids (179) and palmitic acid esters of hydroxyl-stearic acids (PAHSAs) (180) have antiinflammatory and antidiabetic effects. The lipokine palmitoleate suppresses cytokine expression in adipocytes and reverses high fat-induced proinflammatory macrophage polarization (181) . Palmitoleate and PAHSAs are synthesized endogenously in the adipose tissue from fatty acids (180, 182, 183) , and n-3 fatty acids are derived from diet, although palmitoleate is also present in food (183) . Interestingly, adipocyte-specific LPL knockout mice have increased de novo lipogenesis, particularly of palmitoleate. However, this did not increase BAT activation, WAT beiging, or amelioration of inflammation in these mice (184) . PAHSAs and n-3 fatty acids were shown to exert their beneficial metabolic and anti-inflammatory effects via G protein-coupled receptor 120, a receptor for long-chain fatty acids that is present in the gut, adipose tissue, pancreas, and immune cells (180, 185) . Intriguingly, PAHSA levels in mice are the highest in BAT and WAT (180) , and G protein-coupled receptor 120 expression is abundant in BAT and WAT, which increases upon b 3 -adrenergic receptor stimulation or cold (186) . Given the abundance of these metabolically advantageous and anti-inflammatory lipokines in BAT and WAT, future research is needed to unravel the thermogenic effects of lipokines and lipidactivated G protein-coupled receptors.
V. Concluding Remarks and Future Perspectives
A. Translational challenges from mice to men Extensive studies in mouse models have shown that there is a relation between BAT and obesity and that the immune system plays an important role in regulating BAT activity and beiging of WAT, but whether this is the case in humans still needs to be investigated. Although increasing energy expenditure by activating BAT or inducing beiging of WAT prevents diet-induced or genetic obesity in mice, results from different mouse models are not always relevant to the human situation. Interscapular classic BAT in mice does not regress with age, whereas adult humans no longer possess this classic BAT depot. Another difficulty in extrapolating mouse data to the human is the difference in thermoneutral temperature and the activity of BAT at room temperature (18-22°C) . Housing mice in their thermoneutral condition (30°C) would be comparable to the human situation, which is not always acknowledged.
Many studies have shown that BAT activity in humans is thermoresponsive and have suggested that obesity is associated with a decrease in [ 18 F]FDG uptake in BAT, which may be related to inflammation. As described, BAT activity in humans is mostly measured by [ 18 F]FDG uptake. However, the signal generated by [ 18 F]FDG in PET/CT studies likely underestimates the activity of BAT as it uses both glucose and fatty acids as fuel (105, 187) . Furthermore, insulin resistance reduces glucose uptake by BAT, leaving the uptake of fatty acids and oxidative capacity unaffected (105 to quantify BAT activity independent of insulin sensitivity, identification of specific circulating markers for activated human BAT is highly desired. Interestingly, mechanisms of beiging of WAT display more similarities between both species. Mice have a large beiging capacity, especially of the subcutaneous WAT. Although beiging capacity and its contribution to energy expenditure in humans still needs to be determined in detail, studies support a similar mechanism. A 6-week 2-hour daily cold exposure procedure results in the reduction of body fat (2) , and beiging of WAT in patients with pheochromocytoma, a catecholamine-secreting tumor, leads to increased metabolism (188) . Hormones, immune cells, or cytokines that induce beige adipocytes in mice are also present in humans, suggesting that beiging via those mechanisms can also occur in humans. For example, Brestoff et al. (6) confirm the presence of ILC2s in human adipose tissue, suggesting that the circuit of ILC2s, eosinophils, type 2 cytokines, and M2 macrophages that induce beiging in mice is also operational in human beiging.
B. Speculation on human BAT from an evolutionary perspective
BAT evolved as a natural defense system against hypothermia in mammals, increasing the adaptability to explore colder environments (189) . Major threats besides cold in the course of evolution include limited food supply and infections. Cold challenges were accompanied by a limited food supply, making BAT a possible survival organ, enabling efficient food hunting in a subthermal environment (113) .
Formerly common helminth and parasite infections elicit an M2 immune response, which appear to be important regulators of beige adipocytes (6) . Along with the migration to colder areas, both the helminth and host could potentially benefit from increased WAT beiging by promoting host survival in cold climates (190) . Immunity and cold adaptation are therefore connected. Furthermore, as starvation and infection co-occurred, chemokine secretion by adipose tissue could be an evolutionary advantage in which a beneficial genotype to combat infection and higher amounts of adipose tissue promote survival. Another adaptive conservative trait is infectioninduced insulin resistance, enabling nutrient supply to immune cells (191) .
Although BAT seems to have lost part of its function for evolutionary reasons, young people and possibly also adults may still benefit from it. BAT participates in glucose and fatty acid clearance and may still serve as a nutrient buffering system (105, 101) . The role of thermogenesis in handling excessive energy was already shown in a study in 1979, during which diet-induced thermogenesis limited weight gain after a high caloric meal (192) .
C. Therapeutic potential
Potential human drugs that induce beiging of WAT are currently being tested in the clinic, as reviewed by Giordano et al. (193) . A possible target would be the b 3 -adrenergic receptor, although it is not specific for brown adipocytes and is expressed in a variety of organs. Unfortunately, b-adrenergic receptor agonists have so far not been shown to have major effects on energy balance. A latest generation b-adrenergic receptor agonist, mirabegron (approved to treat the overactive bladder), increases the metabolic activity of BAT evidenced by increased [ 18 F]FDG uptake in healthy male participants (99) . In mice, mirabegron also has anti-inflammatory effects (76) . Aside from directly activating brown adipocytes or inducing beiging of WAT with b 3 -adrenergic receptor agonists, anti-inflammatory drugs may induce expansion of BAT and beiging of WAT and promote energy expenditure as an antiobesity treatment, including salsalate or amlexanox (116, 193) . A few drugs with high potential for human drug development target factors downstream of the b 3 -adrenergic receptor, such as CCAAT/enhancerbinding protein b and PRDM16, and have extensively been studied in mice and proven to induce differentiation of beige and brown adipocytes in mice (193) . Besides receptor-targeted drugs, diet and nutritional components as ways to modulate thermogenesis and inflammation can be considered an alternative strategy. Although it is known that brown, beige, and white adipocytes are fueled by glucose and fatty acids, large knowledge gaps exist. We still do not know whether different types of dietary fatty acids or carbohydrates elicit distinct effects on thermogenesis and inflammation. Whereas saturated fatty acids promote inflammation and are detrimental for metabolic health (178), n-3 fatty acids are anti-inflammatory and act beneficially (179) . Whether dietary n-3 fatty acids activate BAT or promote beiging remains to be investigated. An interesting target would be PPARg, which can be activated by these polyunsaturated fatty acids and plays a role in both beige and brown adipogenesis as in M2 anti-inflammatory macrophage activation (194) . As for specific carbohydrates, hardly anything is known about their effects on BAT activity or beiging. Almost 30 years ago, Walgren et al. (195) showed that dietary carbohydrates increased noradrenaline turnover in heart and/or BAT in rats, unrelated to the type of carbohydrate (i.e., fructose, sucrose, dextrose, cornstarch). More recent investigations have not looked into the effects of specific carbohydrates on BAT activation or beiging. Future research might shed light on this underexposed aspect of modulating thermogenesis. press.endocrine.org/journal/edrv
D. Conclusion
Excessive energy intake results in increased storage of lipids in both white and brown adipocytes, which challenges the function of these cells. Immune cells and signals in WAT and BAT are indispensable for the homeostasis of the tissue and contribute to the efflux of lipids stored in white adipocytes and to high rates of oxidation in brown and beige adipocytes.
Immune cells, including eosinophils and alternatively activated macrophages, have regulatory roles in metabolic homeostasis of both WAT and BAT, and research to identify immunological players is ongoing. If the mechanism is unraveled in detail, immune regulation is an intriguing therapeutic target in increasing energy expenditure to reduce weight gain. Notably, the numbers of immune cells in lean as well as obese BAT are much lower than in WAT, indicating that BAT is relatively more resistant to diet-induced inflammation, but increased tissue inflammation in BAT does occur upon a positive energy balance. The challenge is to identify the metabolic crosstalk between immune cells and brown, beige, and white adipocytes and the order of events that occur during obesity development. BAT regulation by the immune system will not come down to an individual immune cell type and will involve substantial crosstalk between different cell types. Important questions to further address include the following: What are the immune regulatory effector molecules that are secreted by brown adipocytes (or a prebeige adipocyte or a whitewanting-to-become-beige adipocyte) to attract or regulate immune cells? How is BAT activity regulated in obesity? What is the role of the sympathetic nerve system? And how does BAT activity change during aging?
In conclusion, the presence of BAT in humans and the potential activation of resident BAT or induction of beige adipocytes in WAT is an interesting target to treat or even prevent obesity-related disorders. Cold is still by far the strongest sympathetic signal to activate BAT, but the quest for identifying biochemical and immunological pathways that are responsible for BAT activation, and thereby can bypass prolonged cold exposure, is ongoing. The recent finding on the role for immune cells in brown and beige adipocyte development and physiology harbors a great potential to increase BAT activity and beneficially alter energy metabolism by interfering in immune responses.
